U-Blot® Research Grade OcankitugCat. No. WA3256Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade OcankitugCat. No. WA3256
U-Blot® Research Grade ObrixtamigCat. No. WA3255
U-Blot® Research Grade ObrindatamabCat. No. WA3254
U-Blot® Research Grade ObinutuzumabCat. No. WA3253
U-Blot® Research Grade ObiltoxaximabCat. No. WA3252
U-Blot® Research Grade ObexelimabCat. No. WA3251
U-Blot® Research Grade ObertamigCat. No. WA3250
U-Blot® Research Grade OberotatugCat. No. WA3249
U-Blot® Research Grade nuvustotugCat. No. WA3248
U-Blot® Research Grade NurulimabCat. No. WA3247
U-Blot® Research Grade notiretatugCat. No. WA3246
U-Blot® Research Grade NolavetbartCat. No. WA3245